Clinical trial

Interleukin-1 Trap to Treat Autoinflammatory Diseases

NCT00094900 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Completed

Key facts

NCT number NCT00094900
Title Interleukin-1 Trap to Treat Autoinflammatory Diseases
Official title Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects With Autoinflammatory Diseases: A Therapeutic Approach to Study Pathogenesis
Lead sponsor National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Inflammation, Familial Mediterranean Fever, Still's Disease, Adult-Onset
Intervention type Drug
Interventions IL-1 Trap
Enrollment 11
Start date Oct 1, 2004
Primary completion Sep 1, 2010
Completion Dec 1, 2010
First posted Oct 28, 2004
Last update posted Mar 4, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies